NCT02493920

Brief Summary

Lung protection should start in the delivery room where, from the first breaths, the preterm infant can be helped to clear the lung fluid and to recruit alveolar spaces and establish the functional residual capacity (FRC). Sustained lung inflation (SLI) applied at birth in the delivery room has been demonstrated to lead to clearance of lung fluid and achievement of a precocious functional residual capacity (FRC) both in animal and human studies. SLI associated to an adequate positive end expiratory pressure (PEEP) may help the efficacy of the respiratory effort in lung of preterm infants at risk for respiratory distress syndrome (RDS) and reduce need of mechanical ventilation (MV). Further studies are required to evaluate the clinical utility of this maneuver. The ability to monitor what happens to the lungs while applying different recruitment maneuvers in preterm infants would allow the definition of a procedure that allows optimal assistance to improve the FRC. One promising approach is provided by the forced oscillation technique (FOT). During forced oscillations, a small amplitude sinusoidal pressure stimulus is applied to the airway opening and the mechanical response of the respiratory system is studied by means of the total respiratory input impedance (Zin). Zin is a complex number that can be expressed as real part, called resistance (Rrs), and imaginary part, called reactance (Xrs). Particularly, it has been recently shown that Xrs measured at 5 Hz is very sensible to changes in the mechanics of lung periphery and provides accurate information about lung volume recruitment and derecruitment. The main purpose of this work is to apply FOT to the assessment of lung function in newborns submitted to SLI at birth. The investigators hypothesized that the application in the delivery room of the SLI in the preterm infant is effective in achieving a greater FRC and therefore a greater value of Xrs compared to a control group not treated with the SLI.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Mar 2016

Typical duration for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 23, 2015

Completed
17 days until next milestone

First Posted

Study publicly available on registry

July 10, 2015

Completed
8 months until next milestone

Study Start

First participant enrolled

March 1, 2016

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2018

Completed
Last Updated

March 2, 2021

Status Verified

February 1, 2021

Enrollment Period

1 year

First QC Date

June 23, 2015

Last Update Submit

February 26, 2021

Conditions

Keywords

Respiratory Distress Syndrome, NewbornDelivery RoomResuscitationPremature birthInfant, NewbornRespiration Artificial

Outcome Measures

Primary Outcomes (1)

  • Change in Reactance (Xrs) values measured by the forced oscillation technique (FOT)

    Baseline and at 5 minutes of life (that is, before and at the end of the SLI)

Secondary Outcomes (9)

  • Need for intubation within the first 72 hours of life

    72 hours of life

  • Duration of respiratory support (ventilation, CPAP, supplemental oxygen)

    During hospitalization - up to 36 weeks Post Menstrual Age (PMA)

  • Death in hospital

    During hospitalization - up to 40 weeks Post Menstrual Age (PMA)

  • Number of surfactant doses

    During hospitalization - up to 36 weeks Post Menstrual Age (PMA)

  • Retinopathy of prematurity (ROP) stage 3 or greater requiring treatment

    40 weeks Post Menstrual Age (PMA)

  • +4 more secondary outcomes

Study Arms (2)

SLI group

EXPERIMENTAL

In this group the preterm infants will receive sustained lung inflation (SLI) with mask in the delivery room; the parameters of respiratory mechanics will be monitored for 5 minutes by means of the forced oscillation technique.

Other: Sustained lung inflationDevice: mask using a T-piece system (Fabian,Acutronic Medical Systems AG, Switzerland).

Control

NO INTERVENTION

Preterm infants will be assisted in the delivery room with a continuous positive airway pressure (CPAP) of 5 cmH2O with mask and the parameters of respiratory mechanics will be monitored for 5 minutes by means of the forced oscillation technique.

Interventions

Sustained lung inflation (SLI) will be performed with mask using a T-piece system (Fabian,Acutronic Medical Systems AG, Switzerland).Peak inflation pressure (PIP) of 25 cm H2O will be delivered for 15 seconds and then reduced to a PEEP of 5 cm H2O. A second SLI manoeuvre will be repeated in case of persistent hearth failure (HR \<100 bpm).

Also known as: lung recruitment
SLI group

Eligibility Criteria

Age25 Weeks - 36 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Gestational age (GA) at least 25 weeks but less than 36 completed weeks by best obstetrical estimate

You may not qualify if:

  • Refusal of antenatal informed consent
  • Known major anomalies, pulmonary hypoplasia
  • Severe perinatal suffering

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Premature BirthRespiratory Distress SyndromeLung DiseasesRespiratory Distress Syndrome, Newborn

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesRespiratory Tract DiseasesRespiration DisordersInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Mariarosa Colnaghi, MD

    NICU, IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical doctor

Study Record Dates

First Submitted

June 23, 2015

First Posted

July 10, 2015

Study Start

March 1, 2016

Primary Completion

March 1, 2017

Study Completion

March 1, 2018

Last Updated

March 2, 2021

Record last verified: 2021-02